GLP Watchdog

Fridays vs Trimrose

Neither Fridays nor Trimrose has an FDA warning letter on record. On brand-name semaglutide pen, Trimrose costs $2,388 less a year at standing rates: $1,299 a month against $1,498 a month at Fridays. It is one of two products the two sell at comparable terms.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Trimrose

Fridays logo

Fridays

5.8/10

Trimrose logo

Trimrose

6.4/10

FDA warning letters
None on record
None on record
Pharmacy
Lowest standing price
$249/moCompounded semaglutide injection
$269/moCompounded semaglutide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit FridaysFull review
Visit TrimroseFull review

Neither Fridays nor Trimrose pays us. Links to them earn nothing. Scores: Fridays 5.8, Trimrose 6.4. How we are paid

What the record shows

  1. 01

    Neither Fridays nor Trimrose has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. Trimrose names seven pharmacies.

  3. 03

    On brand-name semaglutide pen, Trimrose costs $2,388 less a year at standing rates: $1,299 a month against $1,498 a month at Fridays. It is one of two products the two sell at comparable terms.

  4. 04

    Only Fridays lists a price for brand-name tirzepatide pen. Only Trimrose lists a price for compounded oral semaglutide.

  5. 05

    Trimrose lists all 50 states. Fridays publishes no state list.

  6. 06

    Fridays states you can cancel at any time; Trimrose does not state its cancellation terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Trimrose

Compounded semaglutide injection

$249/moLower

$2,988 a year

$269/mo

$3,228 a year

Compounded tirzepatide injection

$359/mo

$4,308 a year

$359/mo

$4,308 a year

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

$1,299/moLower

$15,588 a year

Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$299/mo

$3,588 a year

Price includes
Medication, clinician visits, coaching
Clinician visits, shipping
Cancel any time
Yes, stated
Not stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
None stated (FAQ: no long-term commitments)
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
Not stated

Read off each seller’s own pages. Fridays: September 28, 2026. Trimrose: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • $240 a year less on compounded semaglutide injection
  • Sells brand-name tirzepatide pen, which Trimrose does not price
  • States you can cancel at any time
  • Publishes no state list
Visit Fridays

The case for Trimrose

6.4/10
  • $2,388 a year less on brand-name semaglutide pen
  • Sells compounded oral semaglutide, which Fridays does not price
Visit Trimrose

Scores

Fridays 5.8 · Trimrose 6.4 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
4.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
3.0

Trust & Safety15%

5.5A
vs
B
6.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Trimrose: questions

Neither Fridays nor Trimrose has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Trimrose names seven pharmacies. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Fridays, by $240 a year at standing rates. Fridays: $249 a month, about $2,988 a year. Trimrose: $269 a month, about $3,228 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Trimrose does not state its cancellation terms.
Neither Fridays nor Trimrose pays us. Links to them earn nothing. Scores: Fridays 5.8, Trimrose 6.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks